title: European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.
abstract: OBJECTIVE
  This study seeks to perform a survey of patterns of practice among the different physicians involved in the bone metastases management, with special focus on external beam radiotherapy (EBRT).
  
  
  METHODS
  A questionnaire about bone metastases based on clinical cases and supplemented with general questions, including medical therapies, EBRT and metabolic radiotherapy strategies, surgery, and supportive care approaches, was sent to 4,706 French-speaking physicians in Belgium, France, Luxemburg, and Switzerland.
  
  
  RESULTS
  Overall, 644 questionnaires were analyzed. Twenty-eight percent concerned the radiotherapy approach and were judged adequate to respond to the part dedicated to EBRT. Sixty-nine percent of physicians used a total dose irradiation of 30 Gy delivered in ten fractions. A large majority (75%) used two opposed fields prescribed at mid-depth (30%), or with non-equally weighted fields (45%). Seventy percent irradiated also above and below the concerned vertebra. A dosimetry planning treatment was done in 85% and high-energy megavoltage photons were used in 42%. Moreover, 54% physicians used short course radiotherapy in routine.
  
  
  CONCLUSIONS
  Radiotherapy remains the mainstay of treatment of bone metastases, but there is substantial heterogeneity in clinical practice. Guidelines and treatment protocols are required to improve the treatment quality.
authors.affiliation: Département de Radio-Oncologie, Institut Jules Bordet, Bruxelles, Belgium, nicolas.magne@igr.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Magné
authors.forename: Cyrus
authors.initials: C
authors.lastname: Chargari
authors.forename: René Olivier
authors.initials: RO
authors.lastname: Mirimanoff
authors.forename: Pierre
authors.initials: P
authors.lastname: Olivier
authors.forename: Jean Philippe
authors.initials: JP
authors.lastname: Vuillez
authors.forename: Michèle
authors.initials: M
authors.lastname: Tubiana-Hulin
authors.forename: Jean Jacques
authors.initials: JJ
authors.lastname: Body
authors.forename: Jean Léon
authors.initials: JL
authors.lastname: Lagrange
mesh_terms: D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D002985:Clinical Protocols; D005060:Europe; D019538:Health Care Surveys; D006801:Humans; D007802:Language; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011787:Quality of Health Care; D011879:Radiotherapy Dosage; D011795:Surveys and Questionnaires
references.citation: J Natl Cancer Inst. 2005 Jun 1;97(11):798-804
references.pmid: 15928300
references.citation: Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):161-7
references.pmid: 9747834
references.citation: Radiother Oncol. 1995 Mar;34(3):179-84
references.pmid: 7631024
references.citation: Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1117-24
references.pmid: 9539567
references.citation: Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):1-18
references.pmid: 10219789
references.citation: J Clin Oncol. 2007 Apr 10;25(11):1423-36
references.pmid: 17416863
references.citation: Radiother Oncol. 2000 Sep;56(3):305-14
references.pmid: 10974379
references.citation: Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):715-9
references.pmid: 10524427
references.citation: Radiother Oncol. 2000 Sep;56(3):279-81
references.pmid: 10974375
references.citation: Bone. 1992;13 Suppl 1:S57-62
references.pmid: 1581121
references.citation: Cochrane Database Syst Rev. 2004;(2):CD004721
references.pmid: 15106258
references.citation: Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):594-605
references.pmid: 12573746
references.citation: Radiother Oncol. 1999 Aug;52(2):101-9
references.pmid: 10577695
references.citation: Clin Oncol (R Coll Radiol). 2001;13(2):82-4
references.pmid: 11373883
references.citation: Radiother Oncol. 1999 Aug;52(2):111-21
references.pmid: 10577696
references.citation: Cancer. 1985 Apr 1;55(7):1468-72
references.pmid: 2579716
references.citation: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1473-81
references.pmid: 15817353
references.citation: Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):855-9
references.pmid: 20171810
references.citation: CA Cancer J Clin. 2008 Jul-Aug;58(4):245-59
references.pmid: 18354080
references.citation: Radiother Oncol. 1999 Aug;52(2):95-6
references.pmid: 10577693
references.citation: Int J Radiat Oncol Biol Phys. 1992;23(1):239-44
references.pmid: 1572821
references.citation: Radiother Oncol. 2000 Sep;56(3):315-22
references.pmid: 10974380
references.citation: Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):915-21
references.pmid: 9531377
references.citation: J Clin Oncol. 2003 Jun 1;21(11):2156-62
references.pmid: 12775741
references.citation: Radiother Oncol. 1997 Nov;45(2):109-16
references.pmid: 9423999
references.citation: Radiother Oncol. 2000 Sep;56(3):297-303
references.pmid: 10974378
references.citation: Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1119-26
references.pmid: 9869238
references.citation: Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1083-91
references.pmid: 11958905